2017 Drug Design and Delivery Symposium
This year of the symposium was organized to highlight the work being done by chemists to combat some of the diseases that plague us. Select any of the sessions below to hear experts detail the work that is being done in oncology, anti-infectives and immunology.
| I - Fighting Cancer | |
|---|---|
| January 26 | Fighting Cancer: Targeting CNS Malignancy with Kinase Inhibitors Timothy P. Heffron - Genentech Mark Wittman - Bristol-Myers Squibb |
| February 23 | Fighting Cancer: Epigenetic targets for Oncology Stuart Conway - Oxford Sharan Bagal - AstraZeneca |
| March 23 | Fighting Cancer: Allostery and Targeting Cancer Cell Metabolism Stefan Gross - Agios Scott Edmundson - AstraZeneca |
| Special Broadcast | |
| April 20 | Cystic Fibrosis: Discovery of CFTR Modulators Peter Grootenhuis - Vertex Nick Meanwell - Bristol-Myers Squibb |
| II - Anti-infectives | |
| May 25 | Anti-Infectives: Rational Approaches to the Design and Optimization Jason Sello - Brown University Courtney Aldrich - University of Minnesota |
| June 29 | Tuberculosis: An Introduction for Medicinal Chemists |
| July 27 | Viral Hepatitis: The Search for a Cure Mike Sofia - Arbutus Biopharma Stephen Mason - CaroGen Corporation |
| Special Broadcast | |
| September 28 | Spinal Muscular Atrophy Kevin Hodgetts - Harvard Medical School Alyson Weidmann - ACS Publications |
| III - Immunology | |
| October 26 | Psoriasis: Treatment and Novel Approaches Frank Narjes - AstraZeneca John Morrison - Bristol-Myers Squibb |
| November 30 | Treating Lupus: SLE Pathogenesis and Targeted Therapies Laurence Menard - Bristol-Myers Squibb Mary Struthers - Bristol-Myers Squibb |
Content Advisors
Dan Erlanson
Carmot Therapeutics
Mark Wittman
Bristol-Myers Squibb
;void(0);){kind=link}